Noble Capital Markets is pleased to announce its role as co-manager in the completion of V2X, Inc.'s recent underwritten  underwritten public offering by a certain selling stockholder at the public offering price of $48.00 per share. In connection with the offering, the selling stockholder has granted the underwriters an option to purchase up to 300,000 additional shares of common stock from the selling stockholder. V2X is not selling any shares of common stock in the offering, and V2X will not receive any proceeds from the offering by the selling stockholder.

Noble Capital Markets is pleased to announce its role as co-placement agent for Eledon Pharmaceuticals into a securities purchase agreement with certain institutional and accredited healthcare investors for a private investment in public equity financing that is expected to result in gross proceeds of approximately $50 million, before deducting offering expenses.

Noble Capital Markets is pleased to provide valuation services to Cox Media Group. Noble provided annual impairment analysis per the provisions of Accounting Standards Codification (“ASC”) 350 to Cox Media Group.  

Noble Capital Markets is pleased to announce its role as Co-Manager in The GEO Group, Inc.’s recently announced $1.275 billion Senior Notes Offering. The transaction includes $650 million of 8.625% Senior Subordinated Secured Notes due April 15, 2029 and $625 million of 10.250% Senior Subordinated Unsecured Notes due April 15, 2031.

April 2024 Noble Capital Markets is pleased to provide valuation services to Cumulus Media, Inc. Noble provided annual impairment analysis per the […]

Noble Capital Markets is pleased to announce its role as Co-Manager in the completion of Kratos Defense & Security Solutions, Inc.’s recent underwritten follow-on offering of 16,666,667 shares of its common stock at a price of $18.00 per share. The transaction priced on February 22, 2024.

Noble Capital Markets is pleased to announce its role as a sales agent in The GEO Group, Inc.’s recently announced at-the-market offering of common stock. Under the program, GEO may offer and sell shares having an aggregate offering price of up to $300 million from time to time through a syndicate of sales agents. The transaction was announced on December 28, 2023, pursuant to a shelf registration declared effective on October 30, 2023.

Noble Capital Markets is pleased to announce its role as co-placement agent in connection with Eledon Pharmaceuticals, Inc.’s recently announced private placement of common stock and pre-funded warrants, which is expected to generate gross proceeds of approximately $185 million.